Intuitive Surgical (ISRG), the leader in robotic surgery, has made significant strides during its third quarter 2024, surpassing expectations and generating strong financial growth. The company performed exceptionally with a record high due to demand for its
A.I.-driven Da Vinci Systems. Procedures using the system climbed by
18%, contributing to the robust earnings beat. Analysts have responded optimistically, raising price targets for ISRG to as high as
$555. Questions on overvaluation arose with the pending rollout of the
Da Vinci 5 set for 2025, even as Q3 earnings beat the market. Despite a dip in stock amidst general market gains, ISRG demonstrated resilience with a 6% rise post earning. Investors are advised to watch the advances in this pioneering company if betting on long term investments is their goal. This is especially due to the bullish views from Wall Street. Backed by its strategic positioning and growing trend in AI, ISRG provides an enticing investment opportunity for discerning investors.
Intuitive Surgical ISRG News Analytics from Thu, 18 Jul 2024 07:00:00 GMT to Sat, 19 Oct 2024 17:07:47 GMT -
Rating 9
- Innovation 9
- Rumor 7
